Congenital hypothyroidism and pericardial effusion

Related Experiment Videos

G F Rondanini1, G de Panizza, A Bollati

  • 1H San Raffaele, Department of Pediatrics, University of Milan, Italy.

Hormone Research
|January 1, 1991
PubMed

Insights

Congenital hypothyroidism in infants is linked to a high prevalence of pericardial effusion, especially in severe fetal hormonal defects. This finding suggests cautious L-T4 therapy initiation to prevent cardiac issues.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Screening
  • Cardiology

Background:

  • Congenital hypothyroidism (CH) is a condition diagnosed in newborns.
  • Neonatal screening programs facilitate early detection of CH.
  • Pericardial effusion is a potential complication that requires investigation.

Purpose of the Study:

  • To investigate the prevalence of pericardial effusion in infants with CH.
  • To explore the relationship between the etiology of CH and the presence of pericardial effusion.
  • To inform therapeutic strategies for CH management.

Main Methods:

  • Echocardiography was used to detect pericardial effusion in infants diagnosed with CH via neonatal screening.
  • Thyroid scintiscanning was employed to determine the etiology of hypothyroidism.
  • Data analysis focused on correlating effusion presence with CH causes.

Main Results:

  • A high prevalence of pericardial effusion was observed in infants with CH.
  • The presence of effusion showed a relationship with the specific etiology of CH.
  • Effusion was more frequent in severe forms of CH, such as agenesis or dyshormonogenesis, implying significant fetal hormonal defects.

Conclusions:

  • Pericardial effusion is a common finding in infants with CH, even without other cardiac symptoms.
  • The etiology of CH influences the likelihood of developing pericardial effusion.
  • Initiating L-T4 replacement therapy with lower initial dosages is recommended to mitigate the risk of cardiac involvement.

Related Concept Videos